Table 3 The antibiotics resistance rates of Escherichia coli and Klebsiella pneumoniae
Gram- negative bacteria | Escherichia coli | Klebsiella pneumoniae | ||||||
|---|---|---|---|---|---|---|---|---|
resistance rate(95%CI) | I2 | P value | NO. of study | resistance rate(95%CI) | I2 | P value | NO. of study | |
Ampicillin | 81%(0.72–0.89) | 97% | <0.01 | 22 | 94%(0.88–0.99) | 87% | <0.01 | 16 |
Ampicillin/Sulbactam | 53%(0.45–0.61) | 94% | <0.01 | 14 | 43%(0.27–0.59) | 98% | <0.01 | 11 |
Piperacillin | 66%(0.52–0.78) | 95% | <0.01 | 12 | 57%(0.43–0.70) | 85% | <0.01 | 10 |
Piperacillin/Tazobactam | 05%(0.03–0.08) | 90% | <0.01 | 17 | 10%(0.05–0.16) | 69% | <0.01 | 14 |
Cefazolin | 69%(0.63–0.76) | 94% | <0.01 | 19 | 60%(0.51–0.68) | 68% | <0.01 | 15 |
Cefuroxime sodium | 55%(0.48–0.63) | 93% | <0.01 | 10 | 45%(0.33–0.60) | 89% | <0.01 | 10 |
Cefoxitin | 20%(0.16–0.25) | 81% | <0.01 | 9 | 27%(0.23–0.30) | 54% | 0.03 | 8 |
Ceftazidime | 35%(0.30–0.41) | 90% | <0.01 | 22 | 36%(0.27–0.45) | 74% | <0.01 | 18 |
Ceftriaxone | 51%(0.44–0.58) | 90% | <0.01 | 17 | 49%(0.37–0.60) | 87% | <0.01 | 15 |
Cefotaxime | 54%(0.46–0.63) | 94% | <0.01 | 14 | 45%(0.34–0.56) | 84% | <0.01 | 15 |
Cefoperazone/Sulbactam | 11%(0.06–0.15) | 98% | <0.01 | 12 | 15%(0.07–0.26) | 69% | <0.01 | 11 |
Cefepime | 31%(0.22–0.42) | 97% | <0.01 | 16 | 26%(0.15–0.39) | 81% | <0.01 | 12 |
Amikacin | 6%(0.03–0.10) | 89% | <0.01 | 16 | 14%(0.09–0.22) | 75% | <0.01 | 14 |
Gentamicin | 47%(0.41–0.53) | 89% | <0.01 | 20 | 34%(0.26–0.43) | 74% | <0.01 | 17 |
Ciprofloxacin | 55%(0.47–0.63) | 95% | <0.01 | 19 | 42%(0.31–0.53) | 75% | <0.01 | 16 |
Levofloxacin | 57%(0.50–0.64) | 95% | <0.01 | 22 | 37%(0.29–0.44) | 59% | <0.01 | 18 |
Aztreonam | 43%(0.39–0.47) | 69% | <0.01 | 10 | 37%(0.34–0.41) | 0% | 0.61 | 8 |
Imipenem | 2%(0.00-0.05) | 94% | <0.01 | 25 | 1%(0.00-0.03) | 35% | <0.01 | 18 |
Co-trimoxazole | 62%(0.52–0.71) | 96% | <0.01 | 14 | 58%(0.44–0.72) | 91% | <0.01 | 15 |